18683-91-5

Ambroxol (NA-872) 是前药溴己辛的活性代谢产物，是一种分泌溶解剂，具有强效祛痰作用，用于治疗与粘液或过多粘液相关的呼吸道疾病。它可诱导肺组织细胞自噬，有用于帕金森氏病和神经性戈谢病的研究潜力。它是一种葡糖脑苷脂酶伴侣，可增加葡糖脑苷脂酶的活性。

Ambroxol-D5 is intended for use as an internal standard for the quantification of ambroxol by GC- or LC-MS. Ambroxol (T0920) is an expectorant and active metabolite of bromhexine. It decreases short-circuit currents in electrically stimulated isolated canine tracheal epithelial cells when applied submucosally. Ambroxol (T0920)decreases IL-13-induced production of mucin 5AC (MUC5AC)in primary human airway epithelial cells and inhibits IL-13-induced decreases in the mucociliary transport rate of endogenous particles in the same cells. Ambroxol (T0920)increases phenol red secretion,a marker of expectorant activity,in mice when administered at doses of 30,60,or 120 mg/kg. Formulations containing ambroxol have been used in the treatment of acute or chronic respiratory conditions.